OUR PURPOSE PIONEERING SCIENCE PATIENTS OUR PEOPLE ENVIRONMENT COMMUNITY REPORTING 45 ADVANCING HEALTH ACCESS AND EQUITY BIOGEN 2021 YEAR IN REVIEW Through ongoing partnership with underrepresented and other special population communities and key stakeholders, we are continuously exploring ways to address barriers to clinical trial participation, diagnosis and quality care. For example, we provide lay language clinical trial results to all patients who participate, we aim to translate product information into different languages, and we apply an understanding of how culture affects healthcare decisions. We shared findings from our efforts seeking to better understand the patient journey for those living with Alzheimer’s disease and lupus with the broader ecosystem through presentations at congresses. Learning from and with underserved, underrepresented and other special patient population groups By understanding the impact of socio-demographic and other contributing factors to clinical outcomes, Biogen, collaborators and key stakeholders can better advance disease awareness and create a clear path to quality care. Collaboration highlights In 2021, we began engaging with the National Association of Free and Charitable Clinics (NAFC), a nationwide network of over 1,400 clinics that focuses on ensuring the medically underserved have access to affordable quality healthcare. NAFC clinics provide millions of patient visits each year, mainly to those who do not have health insurance. With the NAFC, we are working to better understand the needs of this population, particularly when it comes to brain health, and to help provide culturally competent disease education for patients and healthcare providers within the NAFC member clinic network. So far, Biogen has shared educational materials and presented to their national network, and we are currently identifying additional opportunities to advance health access and equity together. Last year, Biogen also provided a caregiver presentation at the Black Health Matters Winter Health Summit and participated in two sessions at the Balm in Gilead’s Healthy Churches 2030 Conference, highlighting the disproportionate prevalence of Alzheimer’s disease in the African American community and underscoring the importance of early detection. To help promote health equity, the Biogen Foundation supports CareMessage, the largest patient engagement platform in the U.S., which equips at-risk communities with access to accurate healthcare information using basic text and voice messages. In North Carolina, to date, our support has helped Robson Healthcare and NeighborHealth Center, with plans to extend assistance to a total of 10 safety-net clinics. Þ READ MORE ABOUT THE BIOGEN FOUNDATION Examples of our engagement appear below, reflecting just some of the ways that Biogen engages to better understand and prepare to meet patient needs. SPOTLIGHT Partnering with CVS Health to advance health equity As part of Biogen’s commitment to reduce care disparities in Alzheimer’s disease, we joined forces with CVS Health to add cognitive screenings as an option among the free services offered through CVS Project Health. Project Health events provide free biometric screenings and educational resources to help people identify possible concerns – like high blood pressure and diabetes – before they become serious illnesses. Thanks to Biogen’s support, starting in the fall of 2021, participants at over 700 events across the U.S. had the option to undergo a Mini-Cog© screening – a tool that may increase detection of cognitive impairment in older adults. The tool is a well-established three-minute screening that is widely used in community settings and available in several languages. Mini-Cog tests do not substitute for a complete diagnostic workup, and patients can discuss their results with a healthcare provider for possible follow-up. Project Health participants will also be offered educational resources about mild cognitive impairment from It’s Time, Biogen’s and Eisai’s disease state awareness campaign.